Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
The Omicron variant of SARS-CoV-2 is emerging in communities where people were previously infected with SARS-CoV-2 and are now being vaccinated, or where many people have received two or three coronavirus vaccination doses. More than 130 countries around the globe have implemented booster dose progr...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-02-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/10/3/367 |
| _version_ | 1797441231387623424 |
|---|---|
| author | Vivek P. Chavda Vasso Apostolopoulos |
| author_facet | Vivek P. Chavda Vasso Apostolopoulos |
| author_sort | Vivek P. Chavda |
| collection | DOAJ |
| description | The Omicron variant of SARS-CoV-2 is emerging in communities where people were previously infected with SARS-CoV-2 and are now being vaccinated, or where many people have received two or three coronavirus vaccination doses. More than 130 countries around the globe have implemented booster dose programs for tackling omicron endemics. Despite early findings shows that booster doses may improve omicron protection, more research is needed to establish vaccination efficacy. This short communication tries to critically discuss the research work findings around booster dose strategy for omicron endemics. |
| first_indexed | 2024-03-09T12:20:02Z |
| format | Article |
| id | doaj.art-9b81d87c905f4e1b814f812c661c94f0 |
| institution | Directory Open Access Journal |
| issn | 2076-393X |
| language | English |
| last_indexed | 2024-03-09T12:20:02Z |
| publishDate | 2022-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Vaccines |
| spelling | doaj.art-9b81d87c905f4e1b814f812c661c94f02023-11-30T22:41:58ZengMDPI AGVaccines2076-393X2022-02-0110336710.3390/vaccines10030367Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?Vivek P. Chavda0Vasso Apostolopoulos1Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad 380008, Gujrat, IndiaInstitute for Health and Sport, Victoria University, Melbourne, VIC 3030, AustraliaThe Omicron variant of SARS-CoV-2 is emerging in communities where people were previously infected with SARS-CoV-2 and are now being vaccinated, or where many people have received two or three coronavirus vaccination doses. More than 130 countries around the globe have implemented booster dose programs for tackling omicron endemics. Despite early findings shows that booster doses may improve omicron protection, more research is needed to establish vaccination efficacy. This short communication tries to critically discuss the research work findings around booster dose strategy for omicron endemics.https://www.mdpi.com/2076-393X/10/3/367Omicron variantSARS-CoV-2booster dosevaccine |
| spellingShingle | Vivek P. Chavda Vasso Apostolopoulos Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2? Vaccines Omicron variant SARS-CoV-2 booster dose vaccine |
| title | Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2? |
| title_full | Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2? |
| title_fullStr | Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2? |
| title_full_unstemmed | Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2? |
| title_short | Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2? |
| title_sort | is booster dose strategy sufficient for omicron variant of sars cov 2 |
| topic | Omicron variant SARS-CoV-2 booster dose vaccine |
| url | https://www.mdpi.com/2076-393X/10/3/367 |
| work_keys_str_mv | AT vivekpchavda isboosterdosestrategysufficientforomicronvariantofsarscov2 AT vassoapostolopoulos isboosterdosestrategysufficientforomicronvariantofsarscov2 |